ÂÜÀòÂÒÂ×

Max Dandridge is an experienced project engineer with a strong background in the biopharmaceutical industry. Currently serving as a project engineer at GSK since September 2023, Dandridge previously held similar roles at Resilience and Thermo Fisher Scientific, where responsibilities included leading engineering efforts in the Pharma Services Group's Viral Vector Services. Earlier in the career, Dandridge worked at Sanofi Genzyme, advancing through various engineering positions, contributing to awarded projects such as the Integrated Continuous Biomanufacturing Facility. Dandridge holds a Bachelor of Science in Mechanical Engineering from The George Washington University and has a foundational education from Boston Latin School.